CCZ1 promotes CSCC cell proliferation, colony formation, migration, and invasion by upregulating MMP2 and MMP17 expression, which supports its potential as a therapeutic target for CSCC treatment. This evidence concerns the gene MMP17 and skin squamous cell carcinoma.